ArticleNeoplasia (New York, N.Y.)2013

Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.

Daniele Baiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.